9-FLUORO-2'-(4-FLUOROPHENYL)-11-HYDROXY-16,17-((1-METHYLETHYLIDENE)BIS(OXY))-21-(PHOSPHONOOXY)-2'H-PREGNA-2,4-DIENO(3,2-C)PYRAZOL-20-ONE MONOHYDRATE, (11.BETA.,16.ALPHA.)-
UNII 5QM5U5SUW3
Substance Identification & Data
This profile provides standardized clinical and technical data for 9-fluoro-2'-(4-fluorophenyl)-11-hydroxy-16,17-((1-methylethylidene)bis(oxy))-21-(phosphonooxy)-2'h-pregna-2,4-dieno(3,2-c)pyrazol-20-one Monohydrate, (11.beta.,16.alpha.)-, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 5QM5U5SUW3.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 23293-96-1 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C31H37F2N2O8P.H2O NFLDTHDPWZKMOJ-DHAFDYDHSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 9-fluoro-2'-(4-fluorophenyl)-11-hydroxy-16,17-((1-methylethylidene)bis(oxy))-21-(phosphonooxy)-2'h-pregna-2,4-dieno(3,2-c)pyrazol-20-one Monohydrate, (11.beta.,16.alpha.)-. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.